Safety Study of PT-523 in Cancer Patients to Treat Solid Tumors Including a Preliminary Assessment of Effectiveness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00088023
Recruitment Status : Terminated
First Posted : July 20, 2004
Last Update Posted : March 31, 2014
National Cancer Institute (NCI)
Information provided by:
Spectrum Pharmaceuticals, Inc

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Study Completion Date : December 2005